Vivesto ABFRA:OMA -1.68%33 Market Cap is €8.38 Mil as of Jul. 03, 2026. GuruFocus rates FRA:OMA with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 1,024 Drug Manufacturers companies, Vivesto AB ranks worse than 86.04% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vivesto AB's share price for the quarter that ended in Mar. 2026 was €0.2. Vivesto AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 11.07 Mil. Therefore, Vivesto AB's market cap for the quarter that ended in Mar. 2026 was €2.21 Mil.
Vivesto AB's quarterly market cap
declined
from Sep. 2025 (€9.77 Mil) to Dec. 2025 (€4.95 Mil) and
declined
from Dec. 2025 (€4.95 Mil) to Mar. 2026 (€2.21 Mil).
Vivesto AB's annual market cap
declined
from Dec. 2023 (€24.36 Mil) to Dec. 2024 (€11.93 Mil) and
declined
from Dec. 2024 (€11.93 Mil) to Dec. 2025 (€4.95 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vivesto AB's Enterprise Value for Today is €9.36 Mil.
Vivesto AB (FRA:OMA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Vivesto AB Market Cap Related Terms
Vivesto AB Market Cap Historical Data
* Premium members only.
The historical data trend for Vivesto AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivesto AB Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Vivesto AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Vivesto AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivesto AB (FRA:OMA) has a Market Cap of €8.38 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Vivesto AB and its competitors. According to the industry distribution chart, Vivesto AB ranks #881 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 86%.
Is Vivesto AB's Market Cap too high?
Vivesto AB's current Market Cap is €8.38 Mil. Based on the distribution chart, Vivesto AB ranks #881 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vivesto AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Vivesto AB's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vivesto AB ranks #881 out of 1024 companies for Market Cap. This places Vivesto AB in the lower half of its industry. The industry median Market Cap is 217.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 217.83, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Vivesto AB and its competitors. For the Drug Manufacturers industry, the median Market Cap is 217.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivesto AB's current Market Cap is €8.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivesto AB stock overvalued right now?
Vivesto AB (FRA:OMA) has a current Market Cap of €8.38 Mil. The current Market Cap is €8.38 Mil. Vivesto AB's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Vivesto AB (FRA:OMA), the current Market Cap is €8.38 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
33GF Score
Get the complete analysis for FRA:OMA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OMA has been successfully added to your 
